FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4304208082> ?p ?o ?g. }

• W4304208082 endingPage "10" @default.
• W4304208082 startingPage "1" @default.
• W4304208082 abstract "Background. The long-term continuation of the low-dose antithyroid drug (ATD) beyond the standard duration of ATD therapy of 12–18 months to prevent recurrent hyperthyroidism (RH) is recommended with low quality of evidence. Objectives. To examine whether long-term continuation of low-dose ATD beyond the recommended duration of treatment would provide a benefit in the prevention of RH in patients with Graves’ hyperthyroidism (GH) who achieved euthyroid status with a standard course of ATD therapy. Methods. A 36-month prospective randomized controlled study was conducted in 184 patients who had first diagnosed GH and were treated with a standard regimen of ATD therapy using methimazole (MMI) until achieving euthyroidism that was stably maintained for at least 6 months with a low-dose of (2.5–5 mg/day) MMI. All patients had neither a history of adverse effects from MMI, recurrent GH, severe and active ophthalmopathy nor conditions known to affect thyroid function before randomization. The patients were randomized into 2 groups: one group (92 cases) was assigned to discontinue (DISCONT-MMI) and the other (92 cases) was assigned to continue low-dose MMI (CONT-MMI) that was taken at the time of enrollment. The patients in both groups were followed up at 3, 6, 12, 18, 24, 30, and 36 months. The rate of RH was compared between both groups, and the adverse effects and risk factors of RH were also studied. Results. At the end of the 36-month study, 83 cases in CONT-MMI and 90 cases in DISCONT-MMI were eligible for analysis. The cumulative rates of RH in CONT-MMI were significantly lower than those in DISCONT-MMI at every follow-up time point (1.2% vs. 11.2%, 6.8% vs. 18.4%, 11.0% vs. 27.2%, 11.0% vs. 35.0%, and 11.0% vs. 41.2% at 6, 12, 18, 24, and 36 months, respectively; <math xmlns=http://www.w3.org/1998/Math/MathML id=M1> <mi>p</mi> <mo><</mo> <mn>0.01</mn> </math> ). Cox proportional hazard multivariate analysis showed that there were 2 factors independently associated with the risk of RH, including continuation of low-dose MMI therapy, which decreased the risk of RH by 3.8 times (HR = 0.26, <math xmlns=http://www.w3.org/1998/Math/MathML id=M2> <mi>p</mi> <mo>=</mo> <mn>0.007</mn> </math> , 95% CI = 0.10–0.70) and age onset of hyperthyroidism before 40 years, which increased the risk of RH by 2.9 times (HR = 2.9, <math xmlns=http://www.w3.org/1998/Math/MathML id=M3> <mi>p</mi> <mo>=</mo> <mn>0.015</mn> </math> , 95% CI = 1.23–6.88). Neither minor nor major adverse effects of low-dose MMI therapy were observed during the study period. Conclusions. In Graves’ hyperthyroid patients with no or nonsevere ophthalmopathy who have completed a standard course of methimazole therapy without an adverse effect and have achieved an euthyroid status that is stably maintained with low-dose methimazole, a long-term continuation of the low-dose methimazole of 2.5–5 mg daily is effective and safe in the prevention of recurrent hyperthyroidism or maintenance of euthyroid status as long as the low-dose methimazole is continued. (TCTR20170705002)." @default.
• W4304208082 created "2022-10-11" @default.
• W4304208082 creator A5040027162 @default.
• W4304208082 creator A5059763097 @default.
• W4304208082 creator A5076233027 @default.
• W4304208082 date "2022-10-11" @default.
• W4304208082 modified "2023-09-25" @default.
• W4304208082 title "Benefits of Long-Term Continuation of Low-Dose Methimazole Therapy in the Prevention of Recurrent Hyperthyroidism in Graves’ Hyperthyroid Patients: A Randomized Prospective Controlled Study" @default.
• W4304208082 cites W1980721453 @default.
• W4304208082 cites W1984094434 @default.
• W4304208082 cites W1985645241 @default.
• W4304208082 cites W2024735968 @default.
• W4304208082 cites W2043679683 @default.
• W4304208082 cites W2046240238 @default.
• W4304208082 cites W2051001059 @default.
• W4304208082 cites W2076041344 @default.
• W4304208082 cites W2078686270 @default.
• W4304208082 cites W2085313965 @default.
• W4304208082 cites W2109459078 @default.
• W4304208082 cites W2109826047 @default.
• W4304208082 cites W2112711805 @default.
• W4304208082 cites W2119019874 @default.
• W4304208082 cites W2120811371 @default.
• W4304208082 cites W2134134791 @default.
• W4304208082 cites W2156586495 @default.
• W4304208082 cites W2161176285 @default.
• W4304208082 cites W2167716419 @default.
• W4304208082 cites W2411725411 @default.
• W4304208082 cites W2413013816 @default.
• W4304208082 cites W2415500712 @default.
• W4304208082 cites W2510464317 @default.
• W4304208082 cites W2563590260 @default.
• W4304208082 cites W2884675353 @default.
• W4304208082 cites W2899024476 @default.
• W4304208082 cites W2924420409 @default.
• W4304208082 cites W2947960987 @default.
• W4304208082 cites W2972065880 @default.
• W4304208082 cites W3021945485 @default.
• W4304208082 cites W3024633776 @default.
• W4304208082 cites W3033995410 @default.
• W4304208082 cites W3100244177 @default.
• W4304208082 cites W3186410608 @default.
• W4304208082 doi "https://doi.org/10.1155/2022/1705740" @default.
• W4304208082 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36267362" @default.
• W4304208082 hasPublicationYear "2022" @default.
• W4304208082 type Work @default.
• W4304208082 citedByCount "0" @default.
• W4304208082 crossrefType "journal-article" @default.
• W4304208082 hasAuthorship W4304208082A5040027162 @default.
• W4304208082 hasAuthorship W4304208082A5059763097 @default.
• W4304208082 hasAuthorship W4304208082A5076233027 @default.
• W4304208082 hasBestOaLocation W43042080821 @default.
• W4304208082 hasConcept C126322002 @default.
• W4304208082 hasConcept C141071460 @default.
• W4304208082 hasConcept C168563851 @default.
• W4304208082 hasConcept C187212893 @default.
• W4304208082 hasConcept C188816634 @default.
• W4304208082 hasConcept C197934379 @default.
• W4304208082 hasConcept C204243189 @default.
• W4304208082 hasConcept C2776417830 @default.
• W4304208082 hasConcept C2776606491 @default.
• W4304208082 hasConcept C2776652619 @default.
• W4304208082 hasConcept C2777195454 @default.
• W4304208082 hasConcept C2779761222 @default.
• W4304208082 hasConcept C2781413609 @default.
• W4304208082 hasConcept C2993291352 @default.
• W4304208082 hasConcept C3018694869 @default.
• W4304208082 hasConcept C526584372 @default.
• W4304208082 hasConcept C71924100 @default.
• W4304208082 hasConceptScore W4304208082C126322002 @default.
• W4304208082 hasConceptScore W4304208082C141071460 @default.
• W4304208082 hasConceptScore W4304208082C168563851 @default.
• W4304208082 hasConceptScore W4304208082C187212893 @default.
• W4304208082 hasConceptScore W4304208082C188816634 @default.
• W4304208082 hasConceptScore W4304208082C197934379 @default.
• W4304208082 hasConceptScore W4304208082C204243189 @default.
• W4304208082 hasConceptScore W4304208082C2776417830 @default.
• W4304208082 hasConceptScore W4304208082C2776606491 @default.
• W4304208082 hasConceptScore W4304208082C2776652619 @default.
• W4304208082 hasConceptScore W4304208082C2777195454 @default.
• W4304208082 hasConceptScore W4304208082C2779761222 @default.
• W4304208082 hasConceptScore W4304208082C2781413609 @default.
• W4304208082 hasConceptScore W4304208082C2993291352 @default.
• W4304208082 hasConceptScore W4304208082C3018694869 @default.
• W4304208082 hasConceptScore W4304208082C526584372 @default.
• W4304208082 hasConceptScore W4304208082C71924100 @default.
• W4304208082 hasLocation W43042080821 @default.
• W4304208082 hasLocation W43042080822 @default.
• W4304208082 hasLocation W43042080823 @default.
• W4304208082 hasOpenAccess W4304208082 @default.
• W4304208082 hasPrimaryLocation W43042080821 @default.
• W4304208082 hasRelatedWork W1992647607 @default.
• W4304208082 hasRelatedWork W2000364076 @default.
• W4304208082 hasRelatedWork W2003717079 @default.
• W4304208082 hasRelatedWork W2034400093 @default.
• W4304208082 hasRelatedWork W2047646214 @default.
• W4304208082 hasRelatedWork W2052470019 @default.
• W4304208082 hasRelatedWork W2103445173 @default.

• next